Post by Ipsen

PRESS RELEASE: Breaking data at #EASL2026 expands scientific evidence in primary biliary cholangitis (PBC), a rare liver disease. Findings from real-world evidence and clinical trials show more patients are achieving biochemical control, a key marker of disease progression and gaining fatigue and pruritus (itch) symptom improvements. Read the full press release: https://lnkd.in/danr2cbr